Continuous subcutaneous insulin infusion: Special needs for children

Peter Adolfsson1,2, Ralph Ziegler3, Ragnar Hanas1,4

  • 1Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

Pediatric Diabetes
|April 21, 2017
PubMed

Insights

Insulin pumps for children with type 1 diabetes require specific features like low basal rates for safety and accuracy. Careful selection of devices is crucial for effective continuous subcutaneous insulin infusion (CSII) therapy.

Area of Science:

  • Pediatric Endocrinology
  • Biomedical Engineering

Background:

  • Continuous subcutaneous insulin infusion (CSII) is a primary treatment for pediatric type 1 diabetes.
  • Children have unique physiological needs impacting insulin pump requirements compared to adults.

Purpose of the Study:

  • To highlight the specific challenges and requirements of insulin pump therapy in children.
  • To emphasize the importance of selecting appropriate insulin pumps for pediatric CSII.

Main Methods:

  • Analysis of current insulin pump technology limitations for pediatric use.
  • Review of safety features and accuracy considerations for low basal rates.
  • Discussion of bolus advisor functionalities and connectivity.

Main Results:

  • Standard insulin pumps exhibit decreased accuracy at the very low basal rates required by children.
  • Limited lowest delivered amounts restrict fine-tuning and temporary basal rate options.
  • Delayed occlusion alarms at low basal rates increase the risk of hyperglycemia and diabetic ketoacidosis.

Conclusions:

  • Pediatric CSII requires insulin pumps with high accuracy at low basal rates and responsive safety features.
  • Bolus advisor settings and continuous glucose monitoring integration are vital for safe and effective therapy.
  • Thorough comparison of insulin pump features is essential for optimal pediatric diabetes management.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...